Financials data is unavailable for this security.
View more
Year on year TianYu Bio-Technology Co Ltd 's revenues fell -29.05% from 944.91m to 670.45m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 279.41m to a larger loss of 494.43m.
Gross margin | -20.47% |
---|---|
Net profit margin | -67.63% |
Operating margin | -69.66% |
Return on assets | -13.01% |
---|---|
Return on equity | -46.68% |
Return on investment | -21.49% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at TianYu Bio-Technology Co Ltd fell by 146.51m. Cash Flow from Financing totalled 131.66m or 19.64% of revenues. In addition the company used 175.93m for operations while cash used for investing totalled 102.24m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.25 |
---|---|
Tangible book value per share | 2.13 |
More ▼
Balance sheet in CNYView more
Current ratio | 1.30 |
---|---|
Quick ratio | 1.11 |
Total debt/total equity | 2.13 |
---|---|
Total debt/total capital | 0.6154 |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items dropped -47.47%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 60.96 |